Uncovering the heterogeneity of disease impact in axial spondyloarthritis: bivariate trajectories of disease activity and quality of life
- PMID: 30487997
- PMCID: PMC6241970
- DOI: 10.1136/rmdopen-2018-000755
Uncovering the heterogeneity of disease impact in axial spondyloarthritis: bivariate trajectories of disease activity and quality of life
Abstract
Objective: The goal of managing axial spondyloarthritis (axSpA) is to improve and maintain patients' health-related quality of life (HRQoL), mainly through targeting towards low disease activity. Here, we aim to gain insight into the joint evolution of HRQoL and disease activity by identifying and characterising latent subgroups of patients with longstanding disease displaying similar trajectories throughout 8 years of follow-up.
Methods: Data from Outcome in Ankylosing Spondylitis (AS) International Study (n=161) and Groningen Leeuwarden AS cohort (n=264) were used. Biennially, HRQoL was assessed by AS Quality of Life (ASQoL) and disease activity by AS Disease Activity Score-C reactive protein (ASDAS-CRP). Bivariate trajectories of these outcomes were estimated by group-based trajectory modelling. Next, trajectories were profiled by comparing the latent groups with respect to baseline factors using analysis of variance and χ² test.
Results: Five bivariate trajectories were distinguished, in which ASQoL and ASDAS-CRP were tightly linked: (t1) low impact of disease; (t2) moderate impact; (t3) high impact with major improvement; (t4) high impact with some improvement; (t5) very high impact. Profiling revealed, for example, that (t1) was characterised by male gender and Human Leucocyte Antigen B27 positivity; (t3) by younger age, shorter symptom duration and biological intake and (t5) by the highest proportion of females.
Conclusions: We identified five bivariate trajectories of HRQoL and disease activity demonstrating a clear mutual relationship. The profiles revealed that both individual-related and disease-related features define the type of disease course in respect to HRQoL and disease activity in axSpA. This may provide clinicians insight into the differences among patients and help in the management of the disease.
Keywords: axial spondyloarthritis; disease activity; group-based multi-trajectory modelling; health-related quality of life; trajectories.
Conflict of interest statement
Competing interests: None declared.
Figures

Similar articles
-
Disease activity trajectories in early axial spondyloarthritis: results from the DESIR cohort.Ann Rheum Dis. 2017 Jun;76(6):1036-1041. doi: 10.1136/annrheumdis-2016-209785. Epub 2016 Nov 25. Ann Rheum Dis. 2017. PMID: 27888172
-
Relationship between psychiatric status, self-reported outcome measures, and clinical parameters in axial spondyloarthritis.Medicine (Baltimore). 2014 Dec;93(29):e337. doi: 10.1097/MD.0000000000000337. Medicine (Baltimore). 2014. PMID: 25546683 Free PMC article.
-
Is there any gender-specific difference in the cut-off values of ankylosing spondylitis disease activity score in patients with axial spondyloarthritis?Int J Rheum Dis. 2017 Sep;20(9):1201-1211. doi: 10.1111/1756-185X.12885. Epub 2016 Jun 16. Int J Rheum Dis. 2017. PMID: 27309497
-
Discriminant validity of the Ankylosing Spondylitis Disease Activity Score (ASDAS) in patients with non-radiographic axial spondyloarthritis and ankylosing spondylitis: a cohort study.Rheumatol Int. 2015 Jun;35(6):981-9. doi: 10.1007/s00296-014-3168-y. Epub 2014 Nov 4. Rheumatol Int. 2015. PMID: 25366469
-
The burden of non-radiographic axial spondyloarthritis.Semin Arthritis Rheum. 2015 Apr;44(5):556-562. doi: 10.1016/j.semarthrit.2014.10.009. Epub 2014 Oct 22. Semin Arthritis Rheum. 2015. PMID: 25532945 Review.
Cited by
-
Delayed treatment with a tumor necrosis factor alpha blocker associated with worse outcomes in patients with spondyloarthritis: data from the Czech National Registry ATTRA.Ther Adv Musculoskelet Dis. 2022 Mar 17;14:1759720X221081649. doi: 10.1177/1759720X221081649. eCollection 2022. Ther Adv Musculoskelet Dis. 2022. PMID: 35321118 Free PMC article.
-
The usefulness of diffusion-weighted imaging (DWI) and dynamic contrast-enhanced (DCE) sequences visual assessment in the early diagnosis of axial spondyloarthritis.Rheumatol Int. 2019 Sep;39(9):1559-1565. doi: 10.1007/s00296-019-04373-x. Epub 2019 Jul 10. Rheumatol Int. 2019. PMID: 31292710
-
The impact of gender and sex on diagnosis, treatment outcomes and health-related quality of life in patients with axial spondyloarthritis.Clin Rheumatol. 2022 Nov;41(11):3573-3581. doi: 10.1007/s10067-022-06228-6. Epub 2022 Jun 28. Clin Rheumatol. 2022. PMID: 35763155 Free PMC article. Review.
-
Distinct long-term disease activity trajectories differentiate early on treatment with etanercept in both rheumatoid arthritis and spondylarthritis patients: a prospective cohort study.Rheumatol Int. 2024 Feb;44(2):249-261. doi: 10.1007/s00296-023-05455-7. Epub 2023 Oct 10. Rheumatol Int. 2024. PMID: 37815625 Free PMC article.
-
Gait as predictor of physical function in axial spondyloarthritis: the prospective longitudinal FOLOMI (Function, Locomotion, Measurement, Inflammation) study protocol.Rheumatol Int. 2019 Oct;39(10):1681-1688. doi: 10.1007/s00296-019-04396-4. Epub 2019 Aug 7. Rheumatol Int. 2019. PMID: 31392500
References
-
- van Genderen S, Plasqui G, van der Heijde D. Social role participation and satisfaction with life: a study among patients with ankylosing spondylitis and population controls. Arthritis Care Res 2017. - PubMed
-
- Boonen A. Socioeconomic consequences of ankylosing spondylitis. Clin Exp Rheumatol 2002;20 S23–6. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous